Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Novozymes Biopharma to Showcase World Leading Products at CPhI China

Published: Wednesday, May 29, 2013
Last Updated: Wednesday, May 29, 2013
Bookmark and Share
Innovative range of Hyaluronic Acid, recombinant albumin and enzymes for biocatalysis to be presented alongside insight into China investment.

For the first time, Novozymes Biopharma will showcase its biological-based ingredients and technologies at CPhI China.

The company’s Hyasis™, Recombumin® and biocatalysis products will feature at the pharmaceutical ingredients event, taking place in Shanghai from June 24 - 27 2013.

Importantly, visitors will also have the chance to hear Amber Deng Yue, Regional Marketing Manager for Novozymes Biopharma, present an introduction to the company and its continued investment in operations in China.

“Hyaluronic acid and albumin have significant roles to play in the future of drug development, both in the Chinese market and worldwide,” comments Hemant Pachnanda, business development director at Novozymes Biopharma.

“As the world’s first and only supplier of animal-free recombinant albumins, Recombumin® Prime and Recombumin® Alpha, we work closely with our partners to deliver safe, stable formulations. Recombumin® leads the market in excipients for liquid drug and vaccine formulations, and users can be sure of superior cGMP quality, regulatory support and long-term supply.”

Hyasis® is the next generation of high-quality hyaluronic acid, based on the safe bacteria Bacillus subtilis. Superior heat stability and rapid dissolving time, together with exceptional bath-to-batch consistency characterize the product.

Hyasis® expands the number of possible applications of hyaluronic acid in medical device and pharma products. Novozymes’ Hyasis can be customized further using the company’s proprietary crosslinking technology to achieve a specified viscosity.

This enables the product to be adapted for a wide range of drug delivery and medical device applications including ophthalmology, dermal fillers, osteoarthritis, adhesion prevention, coating and wound healing.

Biocatalysis is an enabling technology which can help pharmaceutical and intermediate manufacturers achieve enhanced sustainability performance, energy cost savings, and decreased raw material costs.

The range of commercial lipases and proteases can be used in chemical transformations in Active Pharmaceutical Ingredient (API) as well as intermediate manufacturing, offering unique advantages.

These include high levels of regioselectivity and stereo selectivity in chemical reactions, reducing the length of the process and the use of expensive, toxic raw materials.

The selection of lipases includes Candida Antartica Lipase B (Lipozyme®CALB L), Candida Antartica Lipase A (NovoCor®AD L), immobilized lipases such as Novozym® 435 and proteases like Alcalase® and Savinase®.

The showcase presentations will take place in the Showcase Area in the exhibition hall at the following timings - 10:00-10:20 for Jun 25th and Jun 26th.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Novozymes Expands Collaboration with Upperton Limited
Conjugating Recombumin® Flex to drugs offers the opportunity to dramatically enhance patient lives and drive down healthcare costs.
Friday, December 09, 2011
Novozymes Biopharma to Present on Creating Market Opportunities Through Drug Half-Life Extension at 2011 BIO Business Forum
Panel session and presentation will explore half-life extension technologies designed to overcome challenges associated with the therapeutic use of peptides and proteins.
Friday, June 24, 2011
Scientific News
Molecular Mechanism For Generating Specific Antibody Responses Discovered
Study could spur more ways to treat autoimmune disease, develop accurate vaccines.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!